Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 7 | 2024 | 149 | 1.390 |
Why?
|
| Sarcoidosis | 4 | 2020 | 11 | 0.900 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 27 | 0.790 |
Why?
|
| Seasons | 1 | 2021 | 112 | 0.760 |
Why?
|
| Comorbidity | 2 | 2017 | 623 | 0.740 |
Why?
|
| Hospital Mortality | 1 | 2021 | 187 | 0.700 |
Why?
|
| Teaching Rounds | 1 | 2019 | 4 | 0.680 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2017 | 2 | 0.610 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 12 | 0.610 |
Why?
|
| Referral and Consultation | 1 | 2017 | 117 | 0.570 |
Why?
|
| Medicaid | 1 | 2017 | 109 | 0.530 |
Why?
|
| Telemedicine | 1 | 2019 | 182 | 0.510 |
Why?
|
| Lung | 3 | 2024 | 446 | 0.510 |
Why?
|
| Socioeconomic Factors | 2 | 2007 | 1067 | 0.270 |
Why?
|
| Humans | 19 | 2024 | 37093 | 0.240 |
Why?
|
| Respiratory Function Tests | 1 | 2024 | 55 | 0.240 |
Why?
|
| Airway Obstruction | 1 | 2024 | 9 | 0.240 |
Why?
|
| United States | 4 | 2021 | 4223 | 0.240 |
Why?
|
| Middle Aged | 9 | 2023 | 10129 | 0.230 |
Why?
|
| Retrospective Studies | 4 | 2021 | 2026 | 0.220 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2002 | 4 | 0.220 |
Why?
|
| Hospitalization | 1 | 2006 | 388 | 0.220 |
Why?
|
| Intensive Care Units | 2 | 2021 | 59 | 0.210 |
Why?
|
| Critical Care | 1 | 2002 | 41 | 0.210 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 217 | 0.200 |
Why?
|
| Adult | 7 | 2024 | 11712 | 0.200 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 12 | 0.190 |
Why?
|
| Vaccines | 1 | 2021 | 55 | 0.190 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2020 | 2 | 0.180 |
Why?
|
| Length of Stay | 1 | 2021 | 185 | 0.180 |
Why?
|
| Liver Diseases | 1 | 2020 | 33 | 0.180 |
Why?
|
| Postoperative Complications | 1 | 2021 | 210 | 0.180 |
Why?
|
| Internship and Residency | 1 | 2021 | 125 | 0.180 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 103 | 0.180 |
Why?
|
| Prognosis | 2 | 2024 | 739 | 0.170 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 56 | 0.170 |
Why?
|
| Male | 10 | 2021 | 20025 | 0.170 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 19 | 0.160 |
Why?
|
| Kidney Diseases | 1 | 2020 | 167 | 0.160 |
Why?
|
| Smoking | 3 | 2023 | 940 | 0.160 |
Why?
|
| Hospitals, University | 1 | 2017 | 38 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2023 | 1492 | 0.150 |
Why?
|
| International Cooperation | 1 | 2017 | 46 | 0.150 |
Why?
|
| Female | 8 | 2021 | 20969 | 0.150 |
Why?
|
| Malaria, Falciparum | 1 | 2018 | 90 | 0.140 |
Why?
|
| Clinical Competence | 1 | 2017 | 130 | 0.140 |
Why?
|
| Quality of Health Care | 1 | 2017 | 138 | 0.140 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 183 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 935 | 0.120 |
Why?
|
| Spirometry | 2 | 2024 | 33 | 0.110 |
Why?
|
| Forced Expiratory Volume | 2 | 2024 | 70 | 0.110 |
Why?
|
| Adolescent | 3 | 2021 | 5363 | 0.110 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 2721 | 0.110 |
Why?
|
| Emphysema | 1 | 2012 | 6 | 0.100 |
Why?
|
| Incidence | 2 | 2021 | 922 | 0.100 |
Why?
|
| Multiple Organ Failure | 2 | 2018 | 7 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 214 | 0.090 |
Why?
|
| Poliovirus | 1 | 1988 | 5 | 0.080 |
Why?
|
| Picornaviridae | 1 | 1988 | 4 | 0.080 |
Why?
|
| Genes | 1 | 1988 | 60 | 0.080 |
Why?
|
| Genes, Viral | 1 | 1988 | 63 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 1988 | 40 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 1988 | 133 | 0.070 |
Why?
|
| Radiography | 1 | 2007 | 72 | 0.070 |
Why?
|
| Quality of Life | 1 | 2011 | 481 | 0.070 |
Why?
|
| Young Adult | 1 | 2017 | 4268 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2007 | 484 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1988 | 173 | 0.070 |
Why?
|
| Polycythemia | 1 | 2006 | 15 | 0.070 |
Why?
|
| Viral Proteins | 1 | 1988 | 174 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2006 | 11 | 0.070 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2006 | 11 | 0.070 |
Why?
|
| Age Distribution | 1 | 2006 | 225 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2006 | 215 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 610 | 0.060 |
Why?
|
| Disease Progression | 1 | 2007 | 601 | 0.060 |
Why?
|
| Dyspnea | 1 | 2024 | 18 | 0.060 |
Why?
|
| Phenotype | 1 | 2006 | 689 | 0.060 |
Why?
|
| Vital Capacity | 1 | 2023 | 39 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 400 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2002 | 3 | 0.050 |
Why?
|
| Plasmapheresis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Risk Factors | 2 | 2011 | 3562 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1130 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2024 | 242 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 39 | 0.050 |
Why?
|
| Critical Illness | 1 | 2021 | 38 | 0.050 |
Why?
|
| Algorithms | 1 | 2024 | 465 | 0.050 |
Why?
|
| Pulmonary Medicine | 1 | 2020 | 2 | 0.050 |
Why?
|
| Endosonography | 1 | 2020 | 3 | 0.050 |
Why?
|
| Mediastinum | 1 | 2020 | 5 | 0.050 |
Why?
|
| Bronchoscopy | 1 | 2020 | 7 | 0.050 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2020 | 12 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 19 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 30 | 0.050 |
Why?
|
| Hypercalcemia | 1 | 2020 | 13 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2020 | 50 | 0.050 |
Why?
|
| Eye Diseases | 1 | 2020 | 24 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 885 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2020 | 66 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2020 | 67 | 0.040 |
Why?
|
| Creatinine | 1 | 2020 | 103 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 80 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 164 | 0.040 |
Why?
|
| Vaccination | 1 | 2021 | 288 | 0.040 |
Why?
|
| Echocardiography | 1 | 2020 | 144 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2020 | 156 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 75 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 494 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 974 | 0.040 |
Why?
|
| Aged | 3 | 2019 | 6741 | 0.040 |
Why?
|
| Antimalarials | 1 | 2018 | 55 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2024 | 642 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 196 | 0.040 |
Why?
|
| Calcium | 1 | 2020 | 480 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 481 | 0.040 |
Why?
|
| Depression | 1 | 2021 | 712 | 0.030 |
Why?
|
| Observer Variation | 1 | 2012 | 52 | 0.030 |
Why?
|
| Education | 1 | 2012 | 55 | 0.030 |
Why?
|
| Linear Models | 1 | 2011 | 275 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 313 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1033 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 167 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 1455 | 0.020 |
Why?
|
| DNA Replication | 1 | 1988 | 152 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2006 | 13 | 0.020 |
Why?
|
| Headache | 1 | 2006 | 19 | 0.020 |
Why?
|
| Vision, Low | 1 | 2006 | 13 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2006 | 39 | 0.020 |
Why?
|
| Virus Replication | 1 | 1988 | 278 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 2379 | 0.020 |
Why?
|